Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
Go back to Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma| (NASDAQ: NTRA) | Delayed: 395.66 -2.11 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $397.77 | 52 Week High | $13.80 | |||
| Open | $396.98 | 52 Week Low | $6.52 | |||
| Day High | $397.53 | P/E | N/A | |||
| Day Low | $383.01 | EPS | $0.00 | |||
| Volume | 1,144,798 | |||||



